iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. The company is headquartered in Woburn, Massachusetts and currently employs 24 full-time employees. The company went IPO on 2021-06-17. The firm addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Ms. Katharyn Field es el President de iSpecimen Inc, se unió a la empresa desde 2024.
¿Qué tal es el rendimiento del precio de la acción ISPC?
El precio actual de ISPC es de $0.2099, ha aumentado un 6.76% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de iSpecimen Inc?
iSpecimen Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de iSpecimen Inc?
La capitalización bursátil actual de iSpecimen Inc es $2.0M
¿Es iSpecimen Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para iSpecimen Inc, incluyendo 2 fuerte compra, 4 compra, 1 mantener, 0 venta, y 2 fuerte venta